Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Once a niche challenge for hardcore athletes, Hyrox has become one of the fastest-growing fitness trends worldwide. It blends elements of endurance running with functional strength work in a way that ...

New analyses out to 24-months showed improvement in heart and lung function compared to expected declines in DMD ...